Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : N::A    tags : Approval    save search

BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: 3.5% H: 4.77% C: 2.39%

lung approval cancer cell treatment for
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.28% C: -0.16%

stelara fda biosimilar approval teva
Exro Announces Shareholder Approval for Proposed Merger with SEA Electric
Published: 2024-04-04 (Crawled : 19:00) - prnewswire.com
EXROF | $0.51 7.21% 100K twitter stocktwits trandingview |
n/a
| | O: -0.6% H: 4.07% C: 1.2%

approval
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
Published: 2024-03-27 (Crawled : 12:30) - globenewswire.com
ALLR | $1.37 -3.52% -3.65% 260K twitter stocktwits trandingview |
n/a
| | O: 0.32% H: 2.87% C: 2.87%

approval cancer therapeutics advanced
Rail Vision Received Approval from Alstom to Install the AI Main Line system on its Locomotives
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
RVSN | $1.1 0.0% 600K twitter stocktwits trandingview |
n/a
| | O: 7.5% H: 0.0% C: -14.53%
ALSMY | News | $1.63 -1.78% 430K twitter stocktwits trandingview |
Manufacturing
| | O: 0.71% H: 1.42% C: 1.42%

approval system vision
Feutune Light Acquisition Corporation Announces Stockholder Approval for Extending Business Combination Deadline and Merger Agreement Amendment with Thunder Power Holdings Limited
Published: 2024-03-20 (Crawled : 03:00) - globenewswire.com
FLFV | $10.91 0.82% 730 twitter stocktwits trandingview |
n/a
| | O: -100.0% H: NaN% C: Infinity%

business approval corporation light deadline acquisition agreement
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CMND | $1.19 -1.65% -1.68% 26K twitter stocktwits trandingview |
n/a
| | O: 1.54% H: 1.52% C: -2.27%

patent granted approval treatment china
Prairie Operating Co. Announces Unanimous Approval of Genesis Oil and Gas Development Plan Adding Multi-Year Inventory of Development Drilling Locations
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
PROP | $14.32 21.15% 17.46% 380K twitter stocktwits trandingview |
n/a
| | O: 0.82% H: 7.26% C: 2.76%

multi-year approval gas oil
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
CMND | $1.19 -1.65% -1.68% 26K twitter stocktwits trandingview |
n/a
| | O: -2.72% H: 1.4% C: -4.9%

approval
BeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: -0.93% H: 3.2% C: 2.66%

fda brukinsa approval treatment
Everything Blockchain Inc. Granted Approval for EB Control Geofencing Patent
Published: 2024-03-05 (Crawled : 14:00) - globenewswire.com
EBZT | $0.5606 -24.29% 24K twitter stocktwits trandingview |
n/a
| | O: 1.69% H: 0.0% C: -0.83%

patent blockchain control granted approval
NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination
Published: 2024-03-05 (Crawled : 12:30) - prnewswire.com
ASCA | $9.16 -56.1% 6.4K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

business approval spac
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
MNKPF | $17.25 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
MNKTQ | $0.12 -66.67% 39K twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

acthar fda drug approval gel application
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
Published: 2024-02-29 (Crawled : 07:00) - prnewswire.com
INVVY | $21.8455 19.02% 8.1K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

approval direct
Energem Corp. Announces Shareholder Approval of Business Combination with Graphjet Technology Sdn. Bhd.
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
ENCP | $12.25 -0.41% 22K twitter stocktwits trandingview |
n/a
| | O: -8.71% H: 5.28% C: -6.22%

business approval technology
Rail Vision Sets New Safety Standards for Europe: Achieves Regulatory Approval and Certificate for Railway Operation in the EU
Published: 2024-02-26 (Crawled : 14:00) - globenewswire.com
RVSN | $1.1 0.0% 600K twitter stocktwits trandingview |
n/a
| | O: -2.07% H: 5.99% C: -6.34%

approval vision
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Published: 2024-02-24 (Crawled : 04:20) - globenewswire.com
KMDA | $5.16 1.18% 1.16% 11K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ALVO | $13.5 0.75% 0.74% 190K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

simlandi first biosimilar approval teva
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Published: 2024-02-23 (Crawled : 12:00) - globenewswire.com
CMND | $1.19 -1.65% -1.68% 26K twitter stocktwits trandingview |
n/a
| | O: 2.15% H: 0.0% C: -1.05%

cmnd-100 alcohol approval trial
Trump-Tied SPAC Jumps on Gaining Long-Awaited SEC Approval – Yahoo Finance
Published: 2024-02-15 (Crawled : 04:00) - spacfeed.com
SCRM S | $10.785 0.14% 0.14% 69K twitter stocktwits trandingview |
n/a
| | O: 0.09% H: 0.0% C: 0.0%

approval spac
Rail Vision Receives Patent Approval from the Indian Patent Office
Published: 2024-02-05 (Crawled : 14:00) - globenewswire.com
RVSN | $1.1 0.0% 600K twitter stocktwits trandingview |
n/a
| | O: 9.46% H: 31.17% C: 5.71%

patent approval
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.